Cargando…

The availability and validity of safety information of over the counter herbal products for use in diabetes in Sri Lanka: A cross sectional study

AIMS: There is an increase of over-the-counter (OTC) herbal products for use in diabetes mellitus. The aim of this study is to evaluate the safety information provided with OTC herbal remedies intended for diabetic patients in Sri Lanka and to assess the completeness of the information provided. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Medagama, Arjuna Bandara, Widanapahirana, Heshan, Prasanga, Tharindu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGEYA 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665020/
https://www.ncbi.nlm.nih.gov/pubmed/26649230
http://dx.doi.org/10.5455/jice.20151104093108
_version_ 1782403534895972352
author Medagama, Arjuna Bandara
Widanapahirana, Heshan
Prasanga, Tharindu
author_facet Medagama, Arjuna Bandara
Widanapahirana, Heshan
Prasanga, Tharindu
author_sort Medagama, Arjuna Bandara
collection PubMed
description AIMS: There is an increase of over-the-counter (OTC) herbal products for use in diabetes mellitus. The aim of this study is to evaluate the safety information provided with OTC herbal remedies intended for diabetic patients in Sri Lanka and to assess the completeness of the information provided. METHODS: Inclusion criteria consisted of OTC herbal remedies meant for use in diabetes. They were bought from local Sri Lankan supermarkets and non-ayurvedic pharmacies and product information regarding the risk of hypoglycemia, precautions for use, adverse events, dose, and interactions were assessed using a scoring system. The accuracy of the information was then compared against published data. RESULTS: 11 products fulfilled the inclusion criteria. Five products contained a single constituent and five contained more than one. None had complete and accurate safety information according to our criteria. None specifically warned against the risk of hypoglycemia. 9 out of 11 products (81.8%) carried ≤3 items of the five essential factual information we expected. Hypoglycemic coma, gastrointestinal symptoms, hepatotoxicity, carcinogenesis, and interactions causing elevated drug levels of Carbamazepine were some of the safety information that was missing. CONCLUSIONS: Key safety information was absent in most products. Regulation of sale, provision of key safety information and adverse event reporting should be a priority.
format Online
Article
Text
id pubmed-4665020
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher SAGEYA
record_format MEDLINE/PubMed
spelling pubmed-46650202015-12-08 The availability and validity of safety information of over the counter herbal products for use in diabetes in Sri Lanka: A cross sectional study Medagama, Arjuna Bandara Widanapahirana, Heshan Prasanga, Tharindu J Intercult Ethnopharmacol Original Research AIMS: There is an increase of over-the-counter (OTC) herbal products for use in diabetes mellitus. The aim of this study is to evaluate the safety information provided with OTC herbal remedies intended for diabetic patients in Sri Lanka and to assess the completeness of the information provided. METHODS: Inclusion criteria consisted of OTC herbal remedies meant for use in diabetes. They were bought from local Sri Lankan supermarkets and non-ayurvedic pharmacies and product information regarding the risk of hypoglycemia, precautions for use, adverse events, dose, and interactions were assessed using a scoring system. The accuracy of the information was then compared against published data. RESULTS: 11 products fulfilled the inclusion criteria. Five products contained a single constituent and five contained more than one. None had complete and accurate safety information according to our criteria. None specifically warned against the risk of hypoglycemia. 9 out of 11 products (81.8%) carried ≤3 items of the five essential factual information we expected. Hypoglycemic coma, gastrointestinal symptoms, hepatotoxicity, carcinogenesis, and interactions causing elevated drug levels of Carbamazepine were some of the safety information that was missing. CONCLUSIONS: Key safety information was absent in most products. Regulation of sale, provision of key safety information and adverse event reporting should be a priority. SAGEYA 2015-11-08 /pmc/articles/PMC4665020/ /pubmed/26649230 http://dx.doi.org/10.5455/jice.20151104093108 Text en Copyright: © SAGEYA http://creativecommons.org/licenses/by-nc/3.0 This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Original Research
Medagama, Arjuna Bandara
Widanapahirana, Heshan
Prasanga, Tharindu
The availability and validity of safety information of over the counter herbal products for use in diabetes in Sri Lanka: A cross sectional study
title The availability and validity of safety information of over the counter herbal products for use in diabetes in Sri Lanka: A cross sectional study
title_full The availability and validity of safety information of over the counter herbal products for use in diabetes in Sri Lanka: A cross sectional study
title_fullStr The availability and validity of safety information of over the counter herbal products for use in diabetes in Sri Lanka: A cross sectional study
title_full_unstemmed The availability and validity of safety information of over the counter herbal products for use in diabetes in Sri Lanka: A cross sectional study
title_short The availability and validity of safety information of over the counter herbal products for use in diabetes in Sri Lanka: A cross sectional study
title_sort availability and validity of safety information of over the counter herbal products for use in diabetes in sri lanka: a cross sectional study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665020/
https://www.ncbi.nlm.nih.gov/pubmed/26649230
http://dx.doi.org/10.5455/jice.20151104093108
work_keys_str_mv AT medagamaarjunabandara theavailabilityandvalidityofsafetyinformationofoverthecounterherbalproductsforuseindiabetesinsrilankaacrosssectionalstudy
AT widanapahiranaheshan theavailabilityandvalidityofsafetyinformationofoverthecounterherbalproductsforuseindiabetesinsrilankaacrosssectionalstudy
AT prasangatharindu theavailabilityandvalidityofsafetyinformationofoverthecounterherbalproductsforuseindiabetesinsrilankaacrosssectionalstudy
AT medagamaarjunabandara availabilityandvalidityofsafetyinformationofoverthecounterherbalproductsforuseindiabetesinsrilankaacrosssectionalstudy
AT widanapahiranaheshan availabilityandvalidityofsafetyinformationofoverthecounterherbalproductsforuseindiabetesinsrilankaacrosssectionalstudy
AT prasangatharindu availabilityandvalidityofsafetyinformationofoverthecounterherbalproductsforuseindiabetesinsrilankaacrosssectionalstudy